Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
study id #: NCT04528355
condition: Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD), Hereditary Anemias, Inflammatory Conditions
status: Recruiting
purpose:This is a data collection study that will examine the general diagnostic and treatment data associated with the reduced-intensity chemotherapy-based regimen paired with simple alemtuzumab dosing strata designed to prevented graft failure and to aid in immune reconstitution following hematopoietic stem cell transplantation.
intervention: data collection
results: https://clinicaltrials.gov/ct2/show/results/NCT04528355
last updated: February 26, 2022
-
Loss of Function of Mutant IDS Due to Endoplasmic Reticulum-Associated Degradation: New Therapeutic Opportunities fo...Mucopolysaccharidosis type II (MPS II) r...
-
Klane K. White, MD, MScKlane K. White, MD, MSc is a Pediatric O...
-
Mucopolysaccharidosis Conditions Explainedhttps://www.youtube.com/watch?v=EmSJ_hGE...
-
Magnetic Resonance Imaging Findings of the Posterior Fossa in 47 Patients With Mucopolysaccharidoses: A Cross-Sectio...Mucopolysaccharidoses (MPS) is a group o...
-
Extraordinary Experiences ProgramProgram provides grants of up to $1000 t...
-
Functioning Profiles of Individuals With Mucopolysaccharidosis According to the International Classification of Func...The classification of health problems of...
-
Bone Biomarkers in MucopolysaccharidosesThe accumulation of glycosaminoglycans (...